China FDA issues guidelines for cell therapy testing

China FDA issued new guidelines concerning development and testing of cell therapy products, including stem cell treatments and immune cell therapies such as chimeric antigen receptor (CAR) T cell therapeutics.

The guidance outlines technical requirements to

Read the full 359 word article

User Sign In